Edwards Lifesciences Corporation (NYSE:EW - Get Free Report) SVP Andrew Dahl sold 544 shares of the business's stock in a transaction on Monday, August 31st. The shares were sold at an average price of $91.06, for a total value of $49,536.64. Following the completion of the sale, the senior vice president owned 14,868 shares of the company's stock, valued at $1,353,880.08. This trade represents a 3.53% decrease in their ownership of the stock. T…